Sign in

CIK 0001736730 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Camp4 Therapeutics Corp

Sign in to watch
Ticker
CAMP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-651-8867
Business address
100 TALCOTT AVENUE, SUITE 201, WATERTOWN, MA, 02472
Open-market buys, last 90 days
$39,600
in 1 filing
Open-market sales, last 90 days
$2,504,037
in 4 filings

Net −$2,464,437. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Schwab Andrew J. −$2.5M Director sold 23% of stake
  2. Gold Kelly +$40K Chief Financial Officer 1 filing
  3. Tardiff Daniel −$8K Chief Scientific Officer sold 100% of stake
Date Insider Transaction Shares Price Value Owned after
2026-08-27 Schwab Andrew J. Director Sale −400,000 $4.04 $1.6M 2,033,270
2026-08-24 Schwab Andrew J. Director Sale −10 $4.50 $45 2,433,270
2026-08-21 Schwab Andrew J. Director Sale −32,018 $4.50 $144K 2,433,280
2026-08-20 Schwab Andrew J. Director Sale −114,700 $4.54 $521K 2,465,298
2026-08-19 Schwab Andrew J. Director Sale −45,147 $4.76 $215K 2,579,998
2026-08-19 Tardiff Daniel Chief Scientific Officer Sale −1,738 $4.76 $8K 0

Page 1 of 1 · 6 trades